Activity of Oritavancin (LY333328), an Investigational Glycopeptide, Compared to That of Vancomycin against Multidrug-Resistant Streptococcus pneumoniae in an In Vitro Pharmacodynamic Model
In the past 2 decades, multidrug-resistant Streptococcus pneumoniae has been encountered with increasing frequency around the world. This has led to the need for newer agents in the treatment of S. pneumoniae infections. Oritavancin (LY333328) is a new glycopeptide antibiotic with activity against g...
Na minha lista:
| 發表在: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society for Microbiology (ASM)
2001
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90360/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11181347/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.45.3.706-709.2001 |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|